(Published in Part II, Section 3, Sub-section (ii) of
the Gazette of India, Extraordinary, dated the 30th November, 2007)
Government of India
Ministry of Chemicals and Fertilizers
National Pharmaceutical Pricing Authority
New Delhi, the 30th November, 2007
ORDER
S.O. 2047(E)- In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637 (E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table below as ceiling prices exclusive of excise duty and local tax, if any, and in column (6) of the table below as Equivalent MRP inclusive of excise duty and education cess, sales tax/VAT of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
Table
| Sl. No. | Name of the formulation | Strength | Pack Size | Ceiling Price (Rs.) | Equivalent MRP* inclusive of all taxes (Rs.) |
|---|---|---|---|---|---|
| (1) | (2) | (3) | (4) | (5) | (6) |
-- |
-- |
Each gm contains | -- |
-- |
-- |
| 1 | Betamethasone Dipropionate+ Zinc Sulphate+ Chlorocresol Cream | Betamethasone Dipropionate eq.to Betamethasone-0.05 %w/w Zinc Sulphate – 0.5 % w/w Chlorocresol – 0.1 % w/w | 30gm Tube | 13.92 | 16.06 |
| 2 | Betamethasone Dipropionate+ Salicylic Acid+ Lactic Acid+ Urea Ointment | Betamethasone Dipropionate – 0.064mg eq. to Betamethasone – 0.05 % Salicylic Acid – 3.00% w/w Lactic Acid – 3.00 %w/w Urea – 10.00 % w/w | 20gm Tube | 10.52 | 12.13 |
| 3 | Betamethasone Dipropionate+ Fusidic Acid+ Chlorocresol Cream | Betamethasone Dipropionate – 0.05% w/w Fusidic Acid – 2% w/w Chlorocresol – 0.1% w/w | 10gm Tube | 23.70 | 27.34 |
| 4 | Betamethasone Dipropionate Gentamicin Cream | Betamethasone Dipropionare eq. to Betametasone 0.05% w/w Gentamicin sulphate eq to Gentamicin base – 0.10% w/w | 30gm Tube | 14.12 | 16.29 |
| 5 | Betamethasone Dipropionate+ Salicylic Acid Ointment | Betamethasone Dipropionare – 0.05% w/w Salicylic Acid – 3% w/w | 30gm Tube | 14.12 | 16.29 |
-- |
-- |
Each ml contains | -- |
-- |
-- |
| 6 | Betamethasone Dipropionate+ Salisylic Acid Lotion | Betamethasone Dipropionate eq.to Betamethasone-0.05 %w/wSalisylic Acid – 3.0 % w/v | 20ml Bottle | 10.04 | 11.58 |
| 7 | Betamethasone+ Methyl Hydroxy Benzoate+ Propyl Hydroxy Benzoate Drops | Betamethasone – 0.5 mg (as Sodium Phosphate ) Methyl Hydroxy Benzoate-0.06% w/w Propyl Hydroxy Benzoate-0.03% w/w | 15ml Bottle with Dropper & Carton | 10.46 | 12.06” |
*Subject to actual payment of Government levies/taxes, as applicable.
Note :
(a) The prices fixed are the maximum retail prices in column (6) (inclusive of excise duty and local taxes if any) for the specified pack and packs of similar strength, and companies cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.
(b) The companies / manufacturers may added taxes only if they have paid actually to the Government on the price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in the Form-V of DPCO, 1995.
(c) Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated 27.1.1998 for tablet and capsule packed in strip/blister.
(d) For different packing material used or any special feature claimed, companies are required to approach NPPA for approval/fixation of specific prices.
(e) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented by the manufacturing /marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(f) The manufacturer and marketing company for the above said formulation shall be required to take the requisite prior approval from the competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
(g) Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the following price order(s) issued prior to this date of notification stand automatically withdrawn :
| Sl.No. | Price Order No. | Date |
|---|---|---|
| . | -- |
-- |
.and any other price order(s) issued earlier for the composition of the formulation pack for which ceiling price is notified in this notification.
PN/97/2007/F
F. No. 8(7)/2007/D.P./NPPA-Div.-II
(RAJIV WADHAWAN)
Deputy Director
Last Page Updated: 01-06-2019
Copyright © 2023 - All Rights Reserved- Official Website of National Pharmaceutical Pricing Authority Ministry of Chemicals and Fertilizers, Government of India
Note :Website Content Managed by National Pharmaceutical Pricing Authority Ministry of Chemicals and Fertilizers, Designed, Developed and Hosted by National Informatics Centre Services Inc.(NICSI)